TrialPsychiatry and clinical neurosciences2020

Randomized, double-blind, placebo-controlled study to assess the efficacy and safety of vortioxetine in Japanese patients with major depressive disorder.

Takeshi Inoue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.